Drug facts
MoleculeLevocarnitine (Carnitor)
Generics already compete: 8 makers on the market. 11 A-rated products from 8 makers substitute at the counter.
Carnitor was first approved by the FDA on 12/27/1985 under NDA 018948; the application holder is Leadiant Biosciences Inc.
The latest NADAC for LEVOCARNITINE 1 G/10 ML SOLN is $0.14 per mL (as of 10/28/2026).
Holder Leadiant Biosciences IncApplication NDA 018948Approved 12/27/1985
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Carnitor patent listed in the Orange Book Orange Book
02Competition
- Generics
- 8 generic makers Orange Book
- First generic approved
- 03/29/2001 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Levocarnitine profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.14 per mLLEVOCARNITINE 1 G/10 ML SOLN, as of 10/28/2026 CMS NADAC
- Latest recall
- 04/16/2026Class III, Levocarnitine, American Regent, Inc. FDA enforcement
04Product
- Application holder
- Leadiant Biosciences Inc Orange Book
- Application
- NDA 018948 Orange Book
- First approved
- 12/27/1985 Orange Book
- Dosage forms
- injectable; solution; tablet
- Routes
- injection, oral
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.